Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul 15:9:932799.
doi: 10.3389/fcvm.2022.932799. eCollection 2022.

Prevalence of a History of Metabolic or Hypertensive Pregnancy Disorder in Patients With Myocardial Infarction and Non-obstructive Coronary Arteries: An Observational Cohort Study

Tobias F S Pustjens  1   2 , Nousjka P A Vranken  1 , Gwyneth Jansen  1   3 , Patty J C Winkler  1 , Mera Stein  1 , Loes Hoebers  1 , Bas Kietselaer  1   2 , Marc E A Spaanderman  3   4 , Saman Rasoul  1   5 , Chahinda Ghossein-Doha  1   2   3   5 , Arnoud W J van 't Hof  1   2   5
Affiliations

Prevalence of a History of Metabolic or Hypertensive Pregnancy Disorder in Patients With Myocardial Infarction and Non-obstructive Coronary Arteries: An Observational Cohort Study

Tobias F S Pustjens et al. Front Cardiovasc Med. .

Abstract

Introduction: Myocardial infarction with non-obstructive coronary arteries (MINOCA) predominantly affects younger females. Women with a history of gestational hypertension (GH), preeclampsia (PE), and gestational diabetes mellitus (GDM) are subjected to an elevated lifetime risk of cardiovascular disease. However, data on the potential association between these obstetric complications and MINOCA is lacking. Therefore, the current study aimed to provide insight in the prevalence of metabolic and hypertensive pregnancy disorders (MHPD) in MINOCA patients and their clinical characteristics.

Methods: In this observational cohort study conducted at the Zuyderland Medical Center and Maastricht University Medical Center in the Netherlands, patients were enrolled if they were identified as having MINOCA. Data on individual patient characteristics, laboratory results, electrocardiography as well as (non-)invasive imaging procedures were derived from the electronic health record system. Patients were asked to complete a questionnaire about prior MHPD including GDM, GH, and PE. Patients were grouped into those with MHPD and those with prior uncomplicated normotensive pregnancy (or pregnancies; NP).

Results: After excluding patients without 1-year follow-up (n = 53), 86 female MINOCA patients remained eligible for analysis. Of the total female population, 25 (29.1%) patients had MHPD, including GH (n = 19; 22.1%), PE (n = 4; 4.7%), and GDM (n = 7; 8.1%). The MHPD patients showed higher rates of chronic hypertension (84.0 vs. 55.7%; p = 0.013), hypercholesterolemia (64.0 vs. 34.4%; p = 0.012), a family history of CVD (84.0 vs. 45.9%; p = 0.001), gout or rheumatic arthritis (16.0 vs. 1.6%; p = 0.024), and were more often non-smokers (45.8 vs. 78.3%; p = 0.004), compared to the NP patients. Moreover, MHPD patients were more likely to use cardiovascular medications at baseline. A trend toward no specific cause found for the MINOCA event was observed in MHPD patients compared to the NP group (64.0 vs. 42.6%, p = 0.072).

Conclusion: A history of metabolic and hypertensive pregnancy disorders occurred in one-third of female MINOCA patients. In these patients, conventional cardiovascular risk factors were more prevalent compared to NP patients. In most MHPD patients, the specific cause for MINOCA remained unclear.

Keywords: MINOCA; cardiovascular risk factor; gestational diabetes; gestational hypertension; preeclampsia.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Flow-chart of included MINOCA patients. *As some patients had multiple metabolic and hypertensive pregnancy disorders, numbers do not sum to 25.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Hauth JC, Ewell MG, Levine RJ, Esterlitz JR, Sibai B, Curet LB, et al. . Pregnancy outcomes in healthy nulliparas who developed hypertension. Calcium for Preeclampsia Prevention Study Group. Obstet Gynecol. (2000) 95:24–8. 10.1097/00006250-200001000-00005 - DOI - PubMed
    1. Shah NS, Wang MC, Freaney PM, Perak AM, Carnethon MR, Kandula NR, et al. . Trends in gestational diabetes at first live birth by race and ethnicity in the US, 2011-2019. JAMA. (2021) 326:660–9. 10.1001/jama.2021.7217 - DOI - PMC - PubMed
    1. Deputy NP, Kim SY, Conrey EJ, Bullard KM. Prevalence and changes in preexisting diabetes and gestational diabetes among women who had a live birth - United States, 2012-2016. MMWR Morb Mortal Wkly Rep. (2018) 67:1201–7. 10.15585/mmwr.mm6743a2 - DOI - PMC - PubMed
    1. Getahun D, Nath C, Ananth CV, Chavez MR, Smulian JC. Gestational diabetes in the United States: temporal trends 1989 through 2004. Am J Obstet Gynecol. (2008) 198:525.e1–5. 10.1016/j.ajog.2007.11.017 - DOI - PubMed
    1. Albrecht SS, Kuklina EV, Bansil P, Jamieson DJ, Whiteman MK, Kourtis AP, et al. . Diabetes trends among delivery hospitalizations in the U.S., 1994-2004. Diabetes Care. (2010) 33:768–73. 10.2337/dc09-1801 - DOI - PMC - PubMed